February 20, 2014Open Access
View Full PaperOutcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
Key Points
- This research aims to compare the outcomes of temporarily interrupting rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation.
- Randomized trial with patients having nonvalvular atrial fibrillation
- Comparison of temporary interruption of rivaroxaban and continued warfarin
- NCT00403767 eligibility and assessment criteria
- Significant differences in bleeding events between groups
- Rivaroxaban interruption leads to lower hospitalization rates
- Improved thromboembolic outcomes observed with rivaroxaban
Abstract
http://www.clinicaltrials.gov. Unique identifier: NCT00403767.